Antiadhesion Molecule Therapy for Refractory Vasculitis: Experience in Five Patients Treated with Humanised Monoclonal anti CD18 Antibodies

Lockwood, C M; Elliott, J D; Waldmann, H

doi:10.1042/cs096010Pb

Article navigation

Conference Abstract| February 01 1999

Antiadhesion Molecule Therapy for Refractory Vasculitis: Experience in Five Patients Treated with Humanised Monoclonal anti CD18 Antibodies

C M Lockwood

Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB1 4HR, England

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

J D Elliott

Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB1 4HR, England

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

H Waldmann

Department of Pathology, University of Oxford, Oxford, England

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (1999) 96 (s40): 10P.

https://doi.org/10.1042/cs096010Pb

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press
5th Floor, 90 High Holborn,
London WC1V 6LJ

Portland Press Tel
+44 (0)20 3880 2795
Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Privacy and cookies
Accessibility

Antiadhesion Molecule Therapy for Refractory Vasculitis: Experience in Five Patients Treated with Humanised Monoclonal anti CD18 Antibodies

Article PDF first page preview

Cited By

Get Email Alerts

CONNECT

EXPLORE

Antiadhesion Molecule Therapy for Refractory Vasculitis: Experience in Five Patients Treated with Humanised Monoclonal anti CD18 Antibodies

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Cited By

Get Email Alerts

Related Articles

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only